Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.

Epperson CN, Haga K, Mason GF, Sellers E, Gueorguieva R, Zhang W, Weiss E, Rothman DL, Krystal JH.

Arch Gen Psychiatry. 2002 Sep;59(9):851-8.

PMID:
12215085
2.

Allopregnanolone and mood disorders.

Bäckström T, Bixo M, Johansson M, Nyberg S, Ossewaarde L, Ragagnin G, Savic I, Strömberg J, Timby E, van Broekhoven F, van Wingen G.

Prog Neurobiol. 2014 Feb;113:88-94. doi: 10.1016/j.pneurobio.2013.07.005. Epub 2013 Aug 23. Review.

PMID:
23978486
3.

Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators.

Andréen L, Nyberg S, Turkmen S, van Wingen G, Fernández G, Bäckström T.

Psychoneuroendocrinology. 2009 Sep;34(8):1121-32. doi: 10.1016/j.psyneuen.2009.02.003. Epub 2009 Mar 9. Review.

PMID:
19272715
4.

GABA receptors, progesterone and premenstrual dysphoric disorder.

Sundström Poromaa I, Smith S, Gulinello M.

Arch Womens Ment Health. 2003 Feb;6(1):23-41. Review.

PMID:
12715262
5.

The role of sex steroids in catamenial epilepsy and premenstrual dysphoric disorder: implications for diagnosis and treatment.

Guille C, Spencer S, Cavus I, Epperson CN.

Epilepsy Behav. 2008 Jul;13(1):12-24. doi: 10.1016/j.yebeh.2008.02.004. Epub 2008 Mar 17. Review.

6.

Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders.

N-Wihlbäck AC, Sundström-Poromaa I, Bäckström T.

Psychopharmacology (Berl). 2006 Jun;186(3):388-401. Epub 2005 Dec 15. Review.

PMID:
16362406
7.

Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder.

Rapkin AJ, Akopians AL.

Menopause Int. 2012 Jun;18(2):52-9. doi: 10.1258/mi.2012.012014. Review.

PMID:
22611222
8.

GABAA Receptor-Modulating Steroids in Relation to Women's Behavioral Health.

Bäckström T, Bixo M, Strömberg J.

Curr Psychiatry Rep. 2015 Nov;17(11):92. doi: 10.1007/s11920-015-0627-4. Review.

PMID:
26396092
9.

Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons.

Bäckström T, Haage D, Löfgren M, Johansson IM, Strömberg J, Nyberg S, Andréen L, Ossewaarde L, van Wingen GA, Turkmen S, Bengtsson SK.

Neuroscience. 2011 Sep 15;191:46-54. doi: 10.1016/j.neuroscience.2011.03.061. Epub 2011 May 13. Review.

PMID:
21600269
10.

Novel aspects of the endocrinology of the menstrual cycle.

Messinis IE, Messini CI, Dafopoulos K.

Reprod Biomed Online. 2014 Jun;28(6):714-22. doi: 10.1016/j.rbmo.2014.02.003. Epub 2014 Mar 4. Review.

PMID:
24745832
11.

Neuroimaging the Menstrual Cycle and Premenstrual Dysphoric Disorder.

Comasco E, Sundström-Poromaa I.

Curr Psychiatry Rep. 2015 Oct;17(10):77. doi: 10.1007/s11920-015-0619-4. Review.

PMID:
26272540
12.

The interaction of neuroactive steroids and GABA in the development of neuropsychiatric disorders in women.

Amin Z, Mason GF, Cavus I, Krystal JH, Rothman DL, Epperson CN.

Pharmacol Biochem Behav. 2006 Aug;84(4):635-43. Epub 2006 Jul 24. Review.

PMID:
16860856
13.

Anxiety sensitivity, the menstrual cycle, and panic disorder: a putative neuroendocrine and psychological interaction.

Nillni YI, Toufexis DJ, Rohan KJ.

Clin Psychol Rev. 2011 Nov;31(7):1183-91. doi: 10.1016/j.cpr.2011.07.006. Epub 2011 Jul 26. Review.

14.

Abnormalities of dorsolateral prefrontal function in women with premenstrual dysphoric disorder: a multimodal neuroimaging study.

Baller EB, Wei SM, Kohn PD, Rubinow DR, Alarcón G, Schmidt PJ, Berman KF.

Am J Psychiatry. 2013 Mar;170(3):305-14. doi: 10.1176/appi.ajp.2012.12030385. Review.

15.

Premenstrual Dysphoric Disorder: Epidemiology and Treatment.

Hantsoo L, Epperson CN.

Curr Psychiatry Rep. 2015 Nov;17(11):87. doi: 10.1007/s11920-015-0628-3. Review.

16.

Altered serotonergic activity in women with dysphoric premenstrual syndromes.

Halbreich U, Tworek H.

Int J Psychiatry Med. 1993;23(1):1-27. Review.

PMID:
8514462
17.

Menstrual cycle-related exacerbation of disease.

Pinkerton JV, Guico-Pabia CJ, Taylor HS.

Am J Obstet Gynecol. 2010 Mar;202(3):221-31. doi: 10.1016/j.ajog.2009.07.061. Review.

18.

Menstrual cycle influence on cognitive function and emotion processing-from a reproductive perspective.

Sundström Poromaa I, Gingnell M.

Front Neurosci. 2014 Nov 24;8:380. doi: 10.3389/fnins.2014.00380. eCollection 2014. Review.

19.

Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation.

Weinberger AH, Smith PH, Allen SS, Cosgrove KP, Saladin ME, Gray KM, Mazure CM, Wetherington CL, McKee SA.

Nicotine Tob Res. 2015 Apr;17(4):407-21. doi: 10.1093/ntr/ntu249. Review.

20.

Neurosteroids in the context of stress: implications for depressive disorders.

Girdler SS, Klatzkin R.

Pharmacol Ther. 2007 Oct;116(1):125-39. Epub 2007 May 24. Review.

Supplemental Content

Support Center